A bone or dental implant material in the form of a paste includes a mixture of calcium phosphate powders, that are capable of forming hydroxyapatite, with liquid glycerol and hydroxypropyl methylcellulose and Na2HPO4. The paste will harden upon exposure to water with the time to harden controlled by the choice and ratio of constituents.

Patent
   6793725
Priority
Jan 24 2001
Filed
Jan 23 2002
Issued
Sep 21 2004
Expiry
Mar 10 2022
Extension
46 days
Assg.orig
Entity
Large
84
55
all paid
7. A paste for bone and tooth restoration comprising, in combination:
a water free mixture of liquid glycerol and powdered tetracalcium phosphate prepared from dicalcium phosphate and calcium carbonate.
1. A composition of matter for dental restoration and bone implants and restoration comprising, in combination:
a mixture of liquid glycerol and a powdered calcium phosphate compound selected from the group consisting of tetracalcium phosphate; anhydrous dicalcium phosphate; α-tricalcium phosphate with calcium carbonate; dicalcium phosphate with calcium hydroxide and mixtures thereof, said mixture being free of water and in the form of a paste.
2. The composition of claim 1 including a cellulose compound.
3. The composition of claim 1 including hydroxypropyl methylcellulose.
4. The composition of claim 1 including Na2HPO4.
5. The composition of claim 1 including an accelerator.
6. The composition of claim 1 comprising a water free paste comprised of a liquid including glycerol, hydroxypropyl methlycellulose and Na2HPO4 and powdered tetracalcium phosphate prepared from dicalcium phosphate and calcium carbonate.
8. The paste of claim 7 wherein the liquid further includes hydroxy methylcellulose.
9. The paste of claim 7 wherein the liquid further includes Na2NPO4.
10. The paste of claim 8 wherein the mass ratio of powder to liquid is in the range of 3.5 to 1 to 1.5 to 1.8.

This is a utility application based upon provisional application Serial No. 60/263,894 filed Jan. 24, 2001 entitled "Premixed Calcium Phosphate Cement Pastes" for which priority is claimed.

This development was supported in part by USPHS Research Grant DE11789 to the American Dental Association Health Foundation from the NIDCR. The United States or an agency thereof may therefor have certain rights to the claimed invention.

A self-hardening calcium phosphate cement, consisting of tetracalcium phosphate (TTCP) and anhydrous dicalcium phosphate has been shown in clinical studies to be efficacious as a bone repair material. The hardening time (HT) of the cement is about 30 minutes when the powder constituents are mixed with water and 5 minutes when mixed with a phosphate solution as the liquid. Hydroxyapatite (HA) is the major product formed as a result of the mixing and hardening. In recent years, additional calcium phosphate cements (CPC) that do not contain TTCP have been developed, e.g. α-tricalcium phosphate (TCP) and CaCO3; dicalcium phosphate (DCPA) and Ca(OH)2). These cements harden in 10 minutes when mixed with a phosphate solution, and they also form HA as the final product.

A cement paste of the type referenced mixed with glycerol was studied for root canal filling, sealing, and injectability and it was reported that the glycerol-calcium phosphate cement (CPC) paste showed better biocompatibility than a number of presently used root canal filling or sealing materials. However, the prior art did not teach a paste material useful as a bone cement that remains stable over a period of time and hardens only when delivered to a desired site.

The present invention comprises compositions and means for formulating premixed glycerol and calcium phosphate cement pastes that are stable in a package, resist washout, and will harden only after being delivered to the defect or implant site. Glycerol was used as the liquid because the CPC hardening reaction to form HA does not occur in a water-free environment. Hydroxypropyl methylcellulose (HMC) and Na2HPO4 were also added to improve the paste cohesiveness and accelerate cement hardening upon delivery to a desired repair site.

TTCP was prepared by heating an equimolar mixture of commercially obtained DCPA and CaCO3 at 1500°C C. for six hours in a furnace and then quenched in air or inert gas to room temperature. Also, TCP was prepared by heating a mixture that contained 2 mol of DCPA and 1 mol of CaCO3 to 1200°C C. for six hours followed by quenching to room temperature. The powders used were ground individually in a planetary ball mill in cyclohexane, ethanol, or dry to obtain the desired median particle size which is about 15 microns and as disclosed in the prior art for making CPC powders.

Nine liquids containing glycerol and various amounts of HMC (in powder form) and Na2HPO4 (in powder form) were then prepared. Their compositions, expressed as mass fractions (%) of HMC and Na2HPO4, are shown in Table 1. The CPC-I, -II and -III were an equimolar mixture of (1) TTCP and DCPA; (2) α-TCP and CaCO3, and (3) DCPA and Ca(OH)2, respectively. CPC pastes were prepared by mixing the prepared CPC powder with the liquid glycerol mixture at powder-to-liquid ratios of 3.5 to 1 to 1.8 to 2.2 and 1.5 to 1.8, respectively. Diametral tensile strength (DTS) samples were prepared by placing the paste into molds (6 mm diameter×3 mm height) with ≈2 MPa of pressure applied. The DTS samples were kept in a mold covered with two fritted glass slides and immersed in a physiologic-like solution (PLS) [1.15 mM Ca, 1.2 mM P, 133 mM NaC1, 50 HEPES, pH=7.4] at 37°C C. Glycerol-PLS exchange occurred through the fritted glass allowing the CPC to harden. Samples were removed at 4 hours, then immersed in PLS for an additional 20 h. A Universal Testing Machine (United Calibration Corp, Garden Grove, Calif., USA) measured DTD values at a loading rate of 10 mm/min. The Gilmore needle method measured HT. Powder X-ray diffraction analysis (XRD) determined the extent of CPC conversion to HA.

All pastes had excellent washout resistance, they remained stable and hardened while immersed in PLS. The HT and the DTS of 24 hour samples are shown in Table 1. The Newman-Kuels multiple comparison test indicated that the Na2HPO4 amount, not the HMC amount, significantly (P<0.05) affected the DTS and HT. Within each group of HMC amount for CPC-I, the lowest phosphate amount substantially increased the DTS while the highest phosphate amount dramatically reduced the HT. For samples CPC-II and -III, the highest phosphate amount significantly increased the DTS and decreased the HT. X-ray diffraction showed only partial conversion of CPC-I to HA and complete conversions of CPC-II and -III to HA in the 24 hour samples.

TABLE 1
Na2NPO4 and HMC compositions expressed as mass
fraction (%) in glycerol, 24 h DTS and HT.
Liquid Na2NPO4 HMC DTS (MPa) HT (Min)
CPC-I
L1 7.5 0.55 4.1 (0.4) 111 (6)
L2 15 0.55 2.8 (0.2) 93 (3)
L3 30 0.55 2.1 (0.2) 62 (2)
L4 7.5 1.1 4.2 (0.2) 97 (8)
L5 15 1.1 2.6 (0.1) 92 (3)
L6 30 1.1 2.6 (0.3) 63 (3)
L7 7.5 2.2 3.6 (0.6) 97 (6)
L8 15 2.2 3.2 (0.3) 93 (3)
L9 30 2.2 2.3 (0.3) 62 (3)
CPC-II
L1 7.5 0.55 2.0 (0.4) 117 (3)
L2 15 0.55 2.5 (0.2) 107 (3)
L3 30 0.55 3.4 (0.4) 80 (5)
CPC-III
L1 7.5 0.55 0* >420
L2 15 0.55 1.0 (0.2) 170 (5)
L3 30 0.55 1.5 (0.1) 125 (5)
Numbers in parentheses denote standard uncertainty (n = 4 and 3 for DTS and HT, respectively).
*Not measurable.

The premixed CPC pastes would generally have a longer hardening time and lower physical strength, but the results suggest that cement pastes with excellent washout resistance can be prepared by incorporating HMC and Na2HPO4 in glycerol. Phosphate generally decreased HT and DTS for CPC-I, and increased DTS for CPC-II and -III. HMC appeared to decrease HA formation for CPC-I, but had no effect for CPC-II and -III, and did not affect DTS.

In sum, formation of a bone replacement or dental replacement paste results by combining dry powder constituents, characterized by their conversion to HA in the presence of water or phosphate solutions, with glycerol and hydroxypropyl methyl cellulose and/or Na2HPO4. The ratio of combined constituents is broad and the resulting paste can be formulated to control rather precisely, the hardening times. Glycerol compounds, analogs and substitutes as well as cellulose analogs and substitutes are within the scope of the invention.

Chow, Laurence C., Takagi, Shozo

Patent Priority Assignee Title
10137061, Nov 16 2004 SOLVENTUM INTELLECTUAL PROPERTIES COMPANY Dental fillers and compositions including phosphate salts
10166104, Apr 25 2006 TELEFLEX MEDICAL INCORPORATED; The University of Connecticut Calcium phosphate polymer composite and method
10182973, Nov 10 2010 STRYKER EUROPEAN HOLDINGS III, LLC Polymeric bone foam composition and method
10286102, May 11 2010 HOWMEDICA OSTEONICS CORP Organophosphorous, multivalent metal compounds, and polymer adhesive interpenetrating network compositions and methods
10973949, Dec 13 2013 Agnovos Healthcare, LLC Multiphasic bone graft substitute material
11185475, Nov 10 2010 STRYKER EUROPEAN HOLDINGS III, LLC Polymeric bone foam composition and method
7066999, Jul 14 1999 Calcitec, Inc. Process for producing fast-setting, bioresorbable calcium phosphate cements
7083749, May 25 2004 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
7083750, Feb 19 2004 Calcitec, Inc. Method for making a porous calcium phosphate article
7097792, May 25 2004 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
7097793, Feb 19 2004 Calcitec, Inc. Method for making a porous calcium phosphate article
7115222, May 25 2004 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
7118695, May 25 2004 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
7119038, Feb 19 2004 Calcitec, Inc. Method for making a porous calcium phosphate article
7122138, May 25 2004 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
7122139, May 25 2004 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
7122140, May 25 2004 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
7128856, May 25 2004 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
7156915, Jul 13 2000 Calcitec, Inc. Tetracalcium phosphate (TTCP) with surface whiskers and method of making same
7157027, May 25 2004 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
7160381, Jul 13 2000 Calcitec, Inc. Tetracalcium phosphate (TTCP) with surface whiskers and method of making same
7160382, Jul 13 2000 Calcitec, Inc. Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same
7163651, Feb 19 2004 CALCITEC, INC Method for making a porous calcium phosphate article
7169373, Jul 14 1999 Calcitec, Inc. Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same
7182895, May 25 2004 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
7182928, Jul 13 2000 Calcitec, Inc. Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same
7186294, Jul 13 2000 Calcitec, Inc. Process for affecting the setting and working time of bioresorbable calcium phosphate cements
7201797, Jul 13 2000 Calcitec, Inc. Process for affecting the setting and working time of, bioresorbable calcium phosphate cements
7204876, Jul 13 2000 Calcitec, Inc. Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same
7214265, Jul 13 2000 Calcitec, Inc. Injectable calcium phosphate cements and the preparation and use thereof
7258734, Jul 14 1999 Calcitec, Inc. Injectable calcium phosphate cements and the preparation and use thereof
7258735, Jul 14 1999 Calcitec, Inc. Process for affecting the setting and working time of bioresorbable calcium phosphate cements
7270705, Jul 14 1999 CALCITEC, INC Method of increasing working time of tetracalcium phosphate cement paste
7279038, Jul 13 2000 Calcitec, Inc. Process for affecting the setting and working time of bioresorbable calcium phosphate cements
7309232, Oct 10 2003 IVOCLAR VIVADENT, INC Methods for treating dental conditions using tissue scaffolds
7416602, Apr 08 2005 HOWMEDICA OSTEONICS CORP Calcium phosphate cement
7459018, Apr 08 2005 HOWMEDICA OSTEONICS CORP Injectable calcium phosphate cement
7588550, Mar 14 2003 Columbia University Systems and methods of blood-based therapies having a microfluidic membraneless exchange device
7709029, Jan 24 2001 ADA Foundation Calcium-containing restoration materials
7727399, May 22 2006 The Trustees of Columbia Univeristy in the City of New York Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams
7754246, Sep 09 2005 Agnovos Healthcare, LLC Composite bone graft substitute cement and articles produced therefrom
7850633, Mar 14 2003 The Trustees of Columbia University in the City of New York Systems and methods of blood-based therapies having a microfluidic membraneless exchange device
7892346, Apr 08 2005 HOWMEDICA OSTEONICS CORP Injectable calcium phosphate cement
7892347, Apr 08 2005 HOWMEDICA OSTEONICS CORP Injectable calcium phosphate cement
7976874, Jul 13 2000 VIVEX BIOLOGICS GROUP, INC Injectable calcium phosphate cements and the preparation and use thereof
8021318, Mar 14 2003 The Trustees of Columbia University in the City of New York Methods of blood-based therapies having a microfluidic membraneless exchange device
8025903, Sep 09 2005 Agnovos Healthcare, LLC Composite bone graft substitute cement and articles produced therefrom
8083706, Mar 14 2003 The Trustees of Columbia University in the City of New York Apparatus and systems for membraneless separation of fluids
8092684, May 22 2006 The Trustees of Columbia University in the City of New York Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams
8097153, May 22 2006 The Trustees of Columbia in the City of New York Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams
8097162, May 22 2006 The Trustees of Columbia University in the City of New York Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams
8105086, Jul 16 2007 Medical and dental biomaterial and method of use for the same
8232327, Nov 12 2008 HOWMEDICA OSTEONICS CORP Tetra calcium phosphate based organophosphorus compositions and methods
8257593, May 22 2007 The Trustees of Columbia University in the City of New York Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams
8273803, Nov 12 2009 Howmedica Osteonics Corp. Tetra calcium phosphate based organophosphorus compositions and methods
8282396, Jan 24 2001 ADA Foundation Calcium-containing restoration materials
8450388, Nov 16 2004 3M Innovative Properties Company Dental fillers, methods, compositions including a caseinate
8470180, May 22 2006 The Trustees of Columbia University in the City of New York Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams
8481065, Dec 18 2009 HOWMEDICA OSTEONICS CORP Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same
8491516, Mar 14 2003 The Trustees of Columbia University in the City of New York Systems and methods for membraneless dialysis
8496606, Feb 04 2008 The Trustees of Columbia University in the City of New York Fluid separation devices, systems and methods
8557038, Apr 22 2009 American Dental Association Foundation Dual-phase calcium phosphate cement composition
8574611, Jul 12 2007 Straumann Holding AG; CAM IMPLANTS B V Composite bone repair material
8580865, Sep 06 2006 curasan AG Phase-and sedimentation-stable, plastically deformable preparation with intrinsic pore forming, intended for example for filling bone defects or for use as bone substitute material, and method of producing it
8685464, Sep 09 2005 Agnovos Healthcare, LLC Composite bone graft substitute cement and articles produced therefrom
8685465, Sep 09 2005 Agnovos Healthcare, LLC Composite bone graft substitute cement and articles produced therefrom
8710114, Nov 16 2004 3M Innovative Properties Company Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof
8722073, Dec 18 2009 Howmedica Osteonics Corp. Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same
8741268, Sep 10 2009 Preventive Technologies, Inc. Dental prophylactic paste
8765189, May 13 2011 HOWMEDICA OSTEONICS CORP Organophosphorous and multivalent metal compound compositions and methods
8790707, Dec 11 2008 SOLVENTUM INTELLECTUAL PROPERTIES COMPANY Surface-treated calcium phosphate particles suitable for oral care and dental compositions
8957126, Nov 07 2005 3M Innovative Properties Company Dental compositions with calcium phosphorus releasing glass
9101436, Oct 21 2005 ADA Foundation Dental and endodontic filling materials and methods
9144631, Jan 27 2003 ASIUS, BENEDICTE; ASIUS, JEROME; RIVIERE, NICOLAS; BORD, JEAN-MICHEL Ceramic-based injectable implants which are used to fill wrinkles, cutaneous depressions and scars, and preparation method thereof
9168114, Oct 17 2013 B & D Dental Corp. Method of making a dental prosthesis
9180224, Sep 09 2005 Agnovos Healthcare, LLC Composite bone graft substitute cement and articles produced therefrom
9233054, Nov 16 2004 3M Innovative Properties Company Dental fillers including a phosphorus-containing surface treatment, and compositions and methods thereof
9259439, Oct 21 2005 ADA Foundation Dual-phase cement precursor systems for bone repair
9265857, May 11 2010 HOWMEDICA OSTEONICS CORP Organophosphorous, multivalent metal compounds, and polymer adhesive interpenetrating network compositions and methods
9414995, Nov 16 2004 3M Innovative Properties Company Dental fillers including a phosphorus-containing surface treatment, and compositions and methods thereof
9446170, Dec 13 2013 Agnovos Healthcare, LLC Multiphasic bone graft substitute material
9517186, Nov 16 2004 3M Innovative Properties Company Dental compositions with calcium phosphorus releasing glass
9642939, Aug 24 2006 Graftys; Universite de Nantes Macroporous and highly resorbable apatitic calcium-phosphate cement
9668825, Oct 21 2005 ADA Foundation Dental and endodontic filling materials and methods
Patent Priority Assignee Title
3679360,
3787900,
3913229,
3929971,
4097935, Aug 02 1974 SANOFI S A Hydroxylapatite ceramic
4486403, Jan 01 1982 Composition for and treatment of teeth
4497075, Oct 08 1979 Mitsubishi Mining & Cement Co., Ltd. Filler for filling in defects or hollow portions of bones
4512038, Apr 27 1979 University of Medicine and Dentistry of New Jersey Bio-absorbable composite tissue scaffold
4518430, Apr 29 1982 American Dental Association Health Foundation; AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION, A CORP ILLINOIS Dental resptorative cement pastes
4599085, Jul 11 1979 Neodontics, Inc. Bone implant member for prostheses and bone connecting elements and process for the production thereof
4612053, Apr 29 1982 American Dental Association Health Foundation Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements
4655777, Dec 19 1983 Southern Research Institute Method of producing biodegradable prosthesis and products therefrom
4880610, Apr 20 1988 Norian Corporation In situ calcium phosphate minerals--method and composition
4897250, Oct 31 1986 Asahi Kogaku Kabushiki Kaisha Process for producing calcium phosphate
4963151, Dec 28 1988 Trustees of the University of Pennsylvania Reinforced bone cement, method of production thereof and reinforcing fiber bundles therefor
5034059, Feb 17 1989 Norian Corporation Composition comprising octacalcium phosphate crystals and polypeptide
5037639, May 24 1989 ADA Foundation Methods and compositions for mineralizing calcified tissues
5047031, Apr 20 1988 NORIAN CORPORATION, 1025 TERRA BELLA AVE , MOUNTAIN VIEW, CA 94043, A CORP OF CA In situ calcium phosphate minerals method
5053212, Apr 20 1988 Norian Corporation Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
5092888, May 19 1989 Tokuyama Soda Kabushiki Kaisha Hardening material
5129905, Apr 20 1988 Norian Corporation Methods for in situ prepared calcium phosphate minerals
5181930, Apr 10 1991 HOWMEDICA OSTEONICS CORP Composite orthopedic implant
5192330, Jan 20 1987 SMITH & NEPHEW RICHARDS, INC Orthopedic device of biocompatible polymer with oriented fiber reinforcement
5236456, Nov 09 1989 Warsaw Orthopedic, Inc Osteogenic composition and implant containing same
5238491, Jul 23 1988 Nitta Gelatin Inc. Hardening material for medical and dental use
5336264, Apr 28 1988 Norian Corporation Situ prepared calcium phosphate composition and method
5455231, Oct 17 1990 Norian Corporation Mineralized collagen
5496399, Aug 23 1994 Norian Corporation Storage stable calcium phosphate cements
5522893, Mar 12 1993 ADA Foundation Calcium phosphate hydroxyapatite precursor and methods for making and using the same
5525148, Sep 24 1993 ADA Foundation Self-setting calcium phosphate cements and methods for preparing and using them
5542973, Mar 12 1993 ADA Foundation Calcium phosphate hydroxyapatite precursor and methods for making and using the same
5545254, Mar 12 1993 ADA Foundation Calcium phosphate hydroxyapatite precursor and methods for making and using the same
5556687, Oct 14 1994 DEPUY ACROMED, INC Composite structure suitable for use as a bone plate and method for making said structure
5652056, Aug 20 1996 Hydroxyapatite filament
5695729, Mar 12 1993 ADA Foundation Calcium phosphate hydroxyapatite precursor and methods for making and using the same
5721049, May 08 1995 TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE Composite materials using bone bioactive glass and ceramic fibers
5766618, Apr 01 1994 Massachusetts Institute of Technology Polymeric-hydroxyapatite bone composite
5782971, Oct 16 1992 Norian Corporation Calcium phosphate cements comprising amorophous calcium phosphate
5962028, Apr 20 1988 Norian Corporation Carbonated hydroxyapatite compositions and uses
5976234, Sep 24 1993 ADA Foundation Self-setting calcium phosphate cements and methods for preparing and using them
5997624, Jun 04 1996 ADA Foundation Self-setting calcium phosphate cements and methods for preparing and using them
6077989, May 28 1996 1208211 ONTARIO LIMITED Resorbable implant biomaterial made of condensed calcium phosphate particles
6136029, Oct 01 1997 Phillips Plastics Corporation Bone substitute materials
6207098, Dec 26 1996 Merck Patent GmbH Method for producing porous inorganic materials
6214008, Apr 16 1997 White Spot AG Biodegradable osteosynthesis implant
6281256, Mar 31 1997 The Regents of the University of Michigan Open pore biodegradable matrices
6281257, Apr 27 1998 MICHIGAN, UNIVERSITY OF THE REGENTS, THE Porous composite materials
6287341, May 19 1995 Etex Corporation Orthopedic and dental ceramic implants
6325992, Mar 12 1993 ADA Foundation Calcium phosphate hydroxyapatite precursor and methods for making and using the same
DE4016135,
EP41676,
EP520690,
RE33161, Apr 29 1982 Stryker Technologies Corporation Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements
RE33221, Apr 29 1982 Stryker Technologies Corporation Dental restorative cement pastes
WO9503369,
////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jan 23 2002ADA Foundation(assignment on the face of the patent)
Feb 06 2002CHOW, LAURENCE C American Dental Association Health FoundationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143930305 pdf
Feb 06 2002TAKAGI, SHOZOAmerican Dental Association Health FoundationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143930305 pdf
Dec 31 2002AMERICAN DENTAL HEALTH ASSCIATION FOUNDATIONADA FoundationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0154430254 pdf
Date Maintenance Fee Events
Feb 21 2008M2551: Payment of Maintenance Fee, 4th Yr, Small Entity.
Oct 26 2011STOL: Pat Hldr no Longer Claims Small Ent Stat
Mar 21 2012M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Mar 21 2016M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Sep 21 20074 years fee payment window open
Mar 21 20086 months grace period start (w surcharge)
Sep 21 2008patent expiry (for year 4)
Sep 21 20102 years to revive unintentionally abandoned end. (for year 4)
Sep 21 20118 years fee payment window open
Mar 21 20126 months grace period start (w surcharge)
Sep 21 2012patent expiry (for year 8)
Sep 21 20142 years to revive unintentionally abandoned end. (for year 8)
Sep 21 201512 years fee payment window open
Mar 21 20166 months grace period start (w surcharge)
Sep 21 2016patent expiry (for year 12)
Sep 21 20182 years to revive unintentionally abandoned end. (for year 12)